Loading…

Resistance reversal action of ketoconazole against mefloquine resistance of Plasmodium yoelii nigeriensis

Ketoconazole at 200 mg/kg dose has been found to exert marginal antimalarial action against multidrug resistant (MDR) Plasmodium yoelii nigeriensis ( P. yoelii nigeriensis) in Swiss mice with 25% protection (2/8 mice) while at lower Ketoconazole dose i.e., 75–100 mg/kg, 14.28% mice were protected. M...

Full description

Saved in:
Bibliographic Details
Published in:Experimental parasitology 2004-07, Vol.107 (3), p.115-119
Main Authors: Awasthi, Aradhana, Dutta, G.P., Bhakuni, Vinod, Tripathi, Renu
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c337t-86b93209c4642e771a3ba553871ed8651716abf637844a90d2fb683fc97eb7353
cites cdi_FETCH-LOGICAL-c337t-86b93209c4642e771a3ba553871ed8651716abf637844a90d2fb683fc97eb7353
container_end_page 119
container_issue 3
container_start_page 115
container_title Experimental parasitology
container_volume 107
creator Awasthi, Aradhana
Dutta, G.P.
Bhakuni, Vinod
Tripathi, Renu
description Ketoconazole at 200 mg/kg dose has been found to exert marginal antimalarial action against multidrug resistant (MDR) Plasmodium yoelii nigeriensis ( P. yoelii nigeriensis) in Swiss mice with 25% protection (2/8 mice) while at lower Ketoconazole dose i.e., 75–100 mg/kg, 14.28% mice were protected. Mefloquine (MFQ) (at 8 and 16 mg/kg) exerted suppressive action against MDR P. yoelii nigeriensis resulting in 25 and 14.28% protection of mice respectively. Combined treatment with Ketoconazole and mefloquine resulted in protection of 5/6 mice (83.33%) at MFQ 4 mg/kg + Ketoconazole 100 mg/kg dose, 7/8 (87.5%) mice at MFQ 8 mg/kg + Ketoconazole 20 mg/kg dose and 5/7 (71.42%) mice at MFQ 16 mg/kg + Ketoconazole 25 mg/kg dose and 5/6 (83.33%) mice at MFQ 16 mg/kg + Ketoconazole 100 mg/kg dose. Ketoconazole has been found to enhance the protective effect of mefloquine against MFQ resistant P. yoelii nigeriensis resulting in 66–88% protection of the mice treated with the appropriate combinations. The combination also increased suppression of parasitaemia at different times. The Ketoconazole combination with MFQ significantly increased the mean survival time of the treated mice compared to individual drugs alone. The study shows that Ketoconazole when administered with MFQ exerts bio-enhancing action against mefloquine resistance of MDR P. yoelii nigeriensis.
doi_str_mv 10.1016/j.exppara.2004.06.001
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66874013</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014489404000992</els_id><sourcerecordid>17829727</sourcerecordid><originalsourceid>FETCH-LOGICAL-c337t-86b93209c4642e771a3ba553871ed8651716abf637844a90d2fb683fc97eb7353</originalsourceid><addsrcrecordid>eNqFkUuLFDEURoMoTjv6E5Ta6K7Km0flsRIZfMGAIroOqdStIW2q0ibVg-OvN00XznJWF8L5ci_nI-QlhY4ClW_3Hf45HFx2HQMQHcgOgD4iOwoGWiaEeUx29UW0QhtxQZ6VsgcATZl4Si5ozyU3XO5I-I4llNUtHpuMt5iLi43za0hLk6bmF67Jp8X9TREbd-PCUtZmximm38ewnCL_05X-Fl2Z0xiOc3OXMIbQLOEGc8ClUs_Jk8nFgi-2eUl-fvzw4-pze_3105er99et51ytrZaD4QyMF1IwVIo6Pri-51pRHLXsqaLSDZPkSgvhDIxsGqTmkzcKB8V7fknenP895HokltXOoXiM0S2YjsVKqZUAyh8EqdLMKKYq2J9Bn1MpGSd7yGF2-c5SsKcy7N5uZdhTGRakrepr7tW24DjMON6nNvsVeL0BrngXp1xFhnLPSco1o1C5d2cOq7fbgNkWX6V6HENGv9oxhQdO-Qek_av5</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17829727</pqid></control><display><type>article</type><title>Resistance reversal action of ketoconazole against mefloquine resistance of Plasmodium yoelii nigeriensis</title><source>Elsevier</source><creator>Awasthi, Aradhana ; Dutta, G.P. ; Bhakuni, Vinod ; Tripathi, Renu</creator><creatorcontrib>Awasthi, Aradhana ; Dutta, G.P. ; Bhakuni, Vinod ; Tripathi, Renu</creatorcontrib><description>Ketoconazole at 200 mg/kg dose has been found to exert marginal antimalarial action against multidrug resistant (MDR) Plasmodium yoelii nigeriensis ( P. yoelii nigeriensis) in Swiss mice with 25% protection (2/8 mice) while at lower Ketoconazole dose i.e., 75–100 mg/kg, 14.28% mice were protected. Mefloquine (MFQ) (at 8 and 16 mg/kg) exerted suppressive action against MDR P. yoelii nigeriensis resulting in 25 and 14.28% protection of mice respectively. Combined treatment with Ketoconazole and mefloquine resulted in protection of 5/6 mice (83.33%) at MFQ 4 mg/kg + Ketoconazole 100 mg/kg dose, 7/8 (87.5%) mice at MFQ 8 mg/kg + Ketoconazole 20 mg/kg dose and 5/7 (71.42%) mice at MFQ 16 mg/kg + Ketoconazole 25 mg/kg dose and 5/6 (83.33%) mice at MFQ 16 mg/kg + Ketoconazole 100 mg/kg dose. Ketoconazole has been found to enhance the protective effect of mefloquine against MFQ resistant P. yoelii nigeriensis resulting in 66–88% protection of the mice treated with the appropriate combinations. The combination also increased suppression of parasitaemia at different times. The Ketoconazole combination with MFQ significantly increased the mean survival time of the treated mice compared to individual drugs alone. The study shows that Ketoconazole when administered with MFQ exerts bio-enhancing action against mefloquine resistance of MDR P. yoelii nigeriensis.</description><identifier>ISSN: 0014-4894</identifier><identifier>EISSN: 1090-2449</identifier><identifier>DOI: 10.1016/j.exppara.2004.06.001</identifier><identifier>PMID: 15363936</identifier><identifier>CODEN: EXPAAA</identifier><language>eng</language><publisher>San Diego, CA: Elsevier Inc</publisher><subject>Animals ; Antimalarials - pharmacology ; Antimalarials - therapeutic use ; Biological and medical sciences ; Dose-Response Relationship, Drug ; Drug Resistance, Multiple - drug effects ; Drug Therapy, Combination ; Fundamental and applied biological sciences. Psychology ; Ketoconazole - pharmacology ; Ketoconazole - therapeutic use ; Life cycle. Host-agent relationship. Pathogenesis ; Malaria - drug therapy ; Malaria - mortality ; Malaria - parasitology ; Mefloquine - pharmacology ; Mefloquine - therapeutic use ; Mice ; Parasitemia - drug therapy ; Parasitemia - mortality ; Parasitemia - parasitology ; Plasmodium yoelii - drug effects ; Plasmodium yoelii nigeriensis ; Protozoa ; Survival Rate</subject><ispartof>Experimental parasitology, 2004-07, Vol.107 (3), p.115-119</ispartof><rights>2004 Elsevier Inc.</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c337t-86b93209c4642e771a3ba553871ed8651716abf637844a90d2fb683fc97eb7353</citedby><cites>FETCH-LOGICAL-c337t-86b93209c4642e771a3ba553871ed8651716abf637844a90d2fb683fc97eb7353</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16138210$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15363936$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Awasthi, Aradhana</creatorcontrib><creatorcontrib>Dutta, G.P.</creatorcontrib><creatorcontrib>Bhakuni, Vinod</creatorcontrib><creatorcontrib>Tripathi, Renu</creatorcontrib><title>Resistance reversal action of ketoconazole against mefloquine resistance of Plasmodium yoelii nigeriensis</title><title>Experimental parasitology</title><addtitle>Exp Parasitol</addtitle><description>Ketoconazole at 200 mg/kg dose has been found to exert marginal antimalarial action against multidrug resistant (MDR) Plasmodium yoelii nigeriensis ( P. yoelii nigeriensis) in Swiss mice with 25% protection (2/8 mice) while at lower Ketoconazole dose i.e., 75–100 mg/kg, 14.28% mice were protected. Mefloquine (MFQ) (at 8 and 16 mg/kg) exerted suppressive action against MDR P. yoelii nigeriensis resulting in 25 and 14.28% protection of mice respectively. Combined treatment with Ketoconazole and mefloquine resulted in protection of 5/6 mice (83.33%) at MFQ 4 mg/kg + Ketoconazole 100 mg/kg dose, 7/8 (87.5%) mice at MFQ 8 mg/kg + Ketoconazole 20 mg/kg dose and 5/7 (71.42%) mice at MFQ 16 mg/kg + Ketoconazole 25 mg/kg dose and 5/6 (83.33%) mice at MFQ 16 mg/kg + Ketoconazole 100 mg/kg dose. Ketoconazole has been found to enhance the protective effect of mefloquine against MFQ resistant P. yoelii nigeriensis resulting in 66–88% protection of the mice treated with the appropriate combinations. The combination also increased suppression of parasitaemia at different times. The Ketoconazole combination with MFQ significantly increased the mean survival time of the treated mice compared to individual drugs alone. The study shows that Ketoconazole when administered with MFQ exerts bio-enhancing action against mefloquine resistance of MDR P. yoelii nigeriensis.</description><subject>Animals</subject><subject>Antimalarials - pharmacology</subject><subject>Antimalarials - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Resistance, Multiple - drug effects</subject><subject>Drug Therapy, Combination</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Ketoconazole - pharmacology</subject><subject>Ketoconazole - therapeutic use</subject><subject>Life cycle. Host-agent relationship. Pathogenesis</subject><subject>Malaria - drug therapy</subject><subject>Malaria - mortality</subject><subject>Malaria - parasitology</subject><subject>Mefloquine - pharmacology</subject><subject>Mefloquine - therapeutic use</subject><subject>Mice</subject><subject>Parasitemia - drug therapy</subject><subject>Parasitemia - mortality</subject><subject>Parasitemia - parasitology</subject><subject>Plasmodium yoelii - drug effects</subject><subject>Plasmodium yoelii nigeriensis</subject><subject>Protozoa</subject><subject>Survival Rate</subject><issn>0014-4894</issn><issn>1090-2449</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNqFkUuLFDEURoMoTjv6E5Ta6K7Km0flsRIZfMGAIroOqdStIW2q0ibVg-OvN00XznJWF8L5ci_nI-QlhY4ClW_3Hf45HFx2HQMQHcgOgD4iOwoGWiaEeUx29UW0QhtxQZ6VsgcATZl4Si5ozyU3XO5I-I4llNUtHpuMt5iLi43za0hLk6bmF67Jp8X9TREbd-PCUtZmximm38ewnCL_05X-Fl2Z0xiOc3OXMIbQLOEGc8ClUs_Jk8nFgi-2eUl-fvzw4-pze_3105er99et51ytrZaD4QyMF1IwVIo6Pri-51pRHLXsqaLSDZPkSgvhDIxsGqTmkzcKB8V7fknenP895HokltXOoXiM0S2YjsVKqZUAyh8EqdLMKKYq2J9Bn1MpGSd7yGF2-c5SsKcy7N5uZdhTGRakrepr7tW24DjMON6nNvsVeL0BrngXp1xFhnLPSco1o1C5d2cOq7fbgNkWX6V6HENGv9oxhQdO-Qek_av5</recordid><startdate>200407</startdate><enddate>200407</enddate><creator>Awasthi, Aradhana</creator><creator>Dutta, G.P.</creator><creator>Bhakuni, Vinod</creator><creator>Tripathi, Renu</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>M7N</scope><scope>7X8</scope></search><sort><creationdate>200407</creationdate><title>Resistance reversal action of ketoconazole against mefloquine resistance of Plasmodium yoelii nigeriensis</title><author>Awasthi, Aradhana ; Dutta, G.P. ; Bhakuni, Vinod ; Tripathi, Renu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c337t-86b93209c4642e771a3ba553871ed8651716abf637844a90d2fb683fc97eb7353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Animals</topic><topic>Antimalarials - pharmacology</topic><topic>Antimalarials - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Resistance, Multiple - drug effects</topic><topic>Drug Therapy, Combination</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Ketoconazole - pharmacology</topic><topic>Ketoconazole - therapeutic use</topic><topic>Life cycle. Host-agent relationship. Pathogenesis</topic><topic>Malaria - drug therapy</topic><topic>Malaria - mortality</topic><topic>Malaria - parasitology</topic><topic>Mefloquine - pharmacology</topic><topic>Mefloquine - therapeutic use</topic><topic>Mice</topic><topic>Parasitemia - drug therapy</topic><topic>Parasitemia - mortality</topic><topic>Parasitemia - parasitology</topic><topic>Plasmodium yoelii - drug effects</topic><topic>Plasmodium yoelii nigeriensis</topic><topic>Protozoa</topic><topic>Survival Rate</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Awasthi, Aradhana</creatorcontrib><creatorcontrib>Dutta, G.P.</creatorcontrib><creatorcontrib>Bhakuni, Vinod</creatorcontrib><creatorcontrib>Tripathi, Renu</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental parasitology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Awasthi, Aradhana</au><au>Dutta, G.P.</au><au>Bhakuni, Vinod</au><au>Tripathi, Renu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Resistance reversal action of ketoconazole against mefloquine resistance of Plasmodium yoelii nigeriensis</atitle><jtitle>Experimental parasitology</jtitle><addtitle>Exp Parasitol</addtitle><date>2004-07</date><risdate>2004</risdate><volume>107</volume><issue>3</issue><spage>115</spage><epage>119</epage><pages>115-119</pages><issn>0014-4894</issn><eissn>1090-2449</eissn><coden>EXPAAA</coden><abstract>Ketoconazole at 200 mg/kg dose has been found to exert marginal antimalarial action against multidrug resistant (MDR) Plasmodium yoelii nigeriensis ( P. yoelii nigeriensis) in Swiss mice with 25% protection (2/8 mice) while at lower Ketoconazole dose i.e., 75–100 mg/kg, 14.28% mice were protected. Mefloquine (MFQ) (at 8 and 16 mg/kg) exerted suppressive action against MDR P. yoelii nigeriensis resulting in 25 and 14.28% protection of mice respectively. Combined treatment with Ketoconazole and mefloquine resulted in protection of 5/6 mice (83.33%) at MFQ 4 mg/kg + Ketoconazole 100 mg/kg dose, 7/8 (87.5%) mice at MFQ 8 mg/kg + Ketoconazole 20 mg/kg dose and 5/7 (71.42%) mice at MFQ 16 mg/kg + Ketoconazole 25 mg/kg dose and 5/6 (83.33%) mice at MFQ 16 mg/kg + Ketoconazole 100 mg/kg dose. Ketoconazole has been found to enhance the protective effect of mefloquine against MFQ resistant P. yoelii nigeriensis resulting in 66–88% protection of the mice treated with the appropriate combinations. The combination also increased suppression of parasitaemia at different times. The Ketoconazole combination with MFQ significantly increased the mean survival time of the treated mice compared to individual drugs alone. The study shows that Ketoconazole when administered with MFQ exerts bio-enhancing action against mefloquine resistance of MDR P. yoelii nigeriensis.</abstract><cop>San Diego, CA</cop><pub>Elsevier Inc</pub><pmid>15363936</pmid><doi>10.1016/j.exppara.2004.06.001</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-4894
ispartof Experimental parasitology, 2004-07, Vol.107 (3), p.115-119
issn 0014-4894
1090-2449
language eng
recordid cdi_proquest_miscellaneous_66874013
source Elsevier
subjects Animals
Antimalarials - pharmacology
Antimalarials - therapeutic use
Biological and medical sciences
Dose-Response Relationship, Drug
Drug Resistance, Multiple - drug effects
Drug Therapy, Combination
Fundamental and applied biological sciences. Psychology
Ketoconazole - pharmacology
Ketoconazole - therapeutic use
Life cycle. Host-agent relationship. Pathogenesis
Malaria - drug therapy
Malaria - mortality
Malaria - parasitology
Mefloquine - pharmacology
Mefloquine - therapeutic use
Mice
Parasitemia - drug therapy
Parasitemia - mortality
Parasitemia - parasitology
Plasmodium yoelii - drug effects
Plasmodium yoelii nigeriensis
Protozoa
Survival Rate
title Resistance reversal action of ketoconazole against mefloquine resistance of Plasmodium yoelii nigeriensis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T04%3A38%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Resistance%20reversal%20action%20of%20ketoconazole%20against%20mefloquine%20resistance%20of%20Plasmodium%20yoelii%20nigeriensis&rft.jtitle=Experimental%20parasitology&rft.au=Awasthi,%20Aradhana&rft.date=2004-07&rft.volume=107&rft.issue=3&rft.spage=115&rft.epage=119&rft.pages=115-119&rft.issn=0014-4894&rft.eissn=1090-2449&rft.coden=EXPAAA&rft_id=info:doi/10.1016/j.exppara.2004.06.001&rft_dat=%3Cproquest_cross%3E17829727%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c337t-86b93209c4642e771a3ba553871ed8651716abf637844a90d2fb683fc97eb7353%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17829727&rft_id=info:pmid/15363936&rfr_iscdi=true